| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 80 | 2024 | 167 | 18.080 |
Why?
|
| Calcium | 112 | 2024 | 472 | 17.230 |
Why?
|
| Calcium Signaling | 55 | 2022 | 169 | 11.520 |
Why?
|
| Sarcoplasmic Reticulum | 51 | 2022 | 209 | 7.050 |
Why?
|
| Heart Atria | 34 | 2023 | 59 | 5.780 |
Why?
|
| Animals | 147 | 2024 | 3377 | 5.270 |
Why?
|
| Action Potentials | 29 | 2024 | 114 | 4.640 |
Why?
|
| Rabbits | 50 | 2024 | 217 | 4.490 |
Why?
|
| Excitation Contraction Coupling | 10 | 2021 | 22 | 4.470 |
Why?
|
| Atrial Fibrillation | 9 | 2024 | 139 | 4.280 |
Why?
|
| Heart Failure | 10 | 2023 | 180 | 3.530 |
Why?
|
| Myocardial Contraction | 23 | 2021 | 62 | 3.420 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 29 | 2017 | 167 | 3.370 |
Why?
|
| Mitochondria, Heart | 16 | 2020 | 18 | 3.130 |
Why?
|
| Arrhythmias, Cardiac | 12 | 2022 | 87 | 2.770 |
Why?
|
| Endothelium, Vascular | 15 | 2017 | 53 | 2.750 |
Why?
|
| Myocardium | 29 | 2022 | 125 | 2.570 |
Why?
|
| Calcium Channels | 14 | 2020 | 120 | 2.500 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 12 | 2023 | 29 | 2.440 |
Why?
|
| Heart Ventricles | 29 | 2017 | 128 | 2.270 |
Why?
|
| Atrial Function | 10 | 2021 | 12 | 2.050 |
Why?
|
| Mitochondria | 11 | 2024 | 66 | 2.050 |
Why?
|
| NFATC Transcription Factors | 5 | 2014 | 14 | 1.850 |
Why?
|
| Heart | 12 | 2017 | 70 | 1.850 |
Why?
|
| Signal Transduction | 21 | 2021 | 380 | 1.770 |
Why?
|
| Cats | 36 | 2013 | 67 | 1.700 |
Why?
|
| Nitric Oxide | 16 | 2014 | 84 | 1.700 |
Why?
|
| Cells, Cultured | 35 | 2020 | 467 | 1.700 |
Why?
|
| Endothelial Cells | 6 | 2017 | 57 | 1.660 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 10 | 2017 | 25 | 1.530 |
Why?
|
| Cytosol | 13 | 2017 | 55 | 1.520 |
Why?
|
| Adenosine Triphosphate | 19 | 2013 | 40 | 1.420 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 14 | 2023 | 34 | 1.390 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 6 | 2023 | 18 | 1.340 |
Why?
|
| Sodium-Calcium Exchanger | 10 | 2022 | 19 | 1.200 |
Why?
|
| Glycolysis | 9 | 2018 | 19 | 1.150 |
Why?
|
| Membrane Potentials | 15 | 2022 | 182 | 1.130 |
Why?
|
| Reactive Oxygen Species | 10 | 2024 | 119 | 1.110 |
Why?
|
| Kinetics | 20 | 2020 | 193 | 1.080 |
Why?
|
| Chloride Channels | 2 | 2016 | 9 | 1.060 |
Why?
|
| Intracellular Membranes | 11 | 2011 | 31 | 1.060 |
Why?
|
| Calcium Channels, L-Type | 6 | 2017 | 57 | 1.030 |
Why?
|
| Microscopy, Confocal | 20 | 2015 | 104 | 1.030 |
Why?
|
| Energy Metabolism | 7 | 2013 | 38 | 0.950 |
Why?
|
| 4-Chloro-7-nitrobenzofurazan | 1 | 2024 | 1 | 0.920 |
Why?
|
| Cattle | 18 | 2011 | 145 | 0.910 |
Why?
|
| Peptide Hormones | 1 | 2023 | 4 | 0.910 |
Why?
|
| Receptors, Adrenergic, beta | 3 | 2013 | 9 | 0.900 |
Why?
|
| Male | 38 | 2020 | 13545 | 0.860 |
Why?
|
| Long QT Syndrome | 1 | 2022 | 7 | 0.840 |
Why?
|
| Sodium | 14 | 2022 | 74 | 0.840 |
Why?
|
| Anti-Arrhythmia Agents | 3 | 2020 | 36 | 0.800 |
Why?
|
| Spermine | 2 | 2020 | 3 | 0.790 |
Why?
|
| Cell Membrane | 10 | 2014 | 92 | 0.750 |
Why?
|
| Organ Specificity | 3 | 2017 | 39 | 0.730 |
Why?
|
| Patch-Clamp Techniques | 10 | 2017 | 107 | 0.730 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2020 | 28 | 0.710 |
Why?
|
| Endoplasmic Reticulum | 5 | 2017 | 18 | 0.710 |
Why?
|
| Heart Conduction System | 3 | 2014 | 14 | 0.640 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 7 | 2015 | 8 | 0.640 |
Why?
|
| Calcium-Transporting ATPases | 5 | 2004 | 22 | 0.630 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 5 | 2007 | 18 | 0.620 |
Why?
|
| Cell Nucleus | 6 | 2014 | 74 | 0.610 |
Why?
|
| Pulmonary Artery | 7 | 2010 | 40 | 0.610 |
Why?
|
| Atrial Remodeling | 2 | 2019 | 2 | 0.600 |
Why?
|
| Urocortins | 2 | 2014 | 3 | 0.580 |
Why?
|
| In Vitro Techniques | 14 | 2012 | 169 | 0.580 |
Why?
|
| NAD | 4 | 2004 | 6 | 0.560 |
Why?
|
| Nitric Oxide Synthase | 5 | 2013 | 44 | 0.550 |
Why?
|
| Chloride Channel Agonists | 1 | 2016 | 2 | 0.540 |
Why?
|
| Magnesium | 9 | 2013 | 45 | 0.540 |
Why?
|
| Rats | 22 | 2019 | 598 | 0.520 |
Why?
|
| Microscopy, Fluorescence | 10 | 2010 | 77 | 0.520 |
Why?
|
| Mitochondrial Membranes | 2 | 2013 | 3 | 0.510 |
Why?
|
| Ion Channel Gating | 6 | 2017 | 183 | 0.510 |
Why?
|
| Fluorescent Dyes | 14 | 2013 | 51 | 0.510 |
Why?
|
| Caffeine | 11 | 2011 | 60 | 0.490 |
Why?
|
| Proto-Oncogene Proteins c-akt | 5 | 2021 | 49 | 0.490 |
Why?
|
| Uncoupling Agents | 2 | 2013 | 4 | 0.490 |
Why?
|
| Receptors, Adrenergic, beta-2 | 2 | 2012 | 4 | 0.470 |
Why?
|
| Electrocardiography | 1 | 2014 | 112 | 0.460 |
Why?
|
| Muscle, Smooth, Vascular | 4 | 1995 | 7 | 0.440 |
Why?
|
| Trimetazidine | 1 | 2013 | 1 | 0.430 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2012 | 2 | 0.420 |
Why?
|
| Humans | 24 | 2021 | 25178 | 0.410 |
Why?
|
| Refractory Period, Electrophysiological | 1 | 2012 | 2 | 0.410 |
Why?
|
| Dantrolene | 1 | 2011 | 2 | 0.400 |
Why?
|
| Enzyme Inhibitors | 11 | 2011 | 121 | 0.400 |
Why?
|
| Calmodulin | 4 | 2023 | 9 | 0.390 |
Why?
|
| Ion Transport | 7 | 2014 | 35 | 0.380 |
Why?
|
| Tetracaine | 2 | 2007 | 10 | 0.370 |
Why?
|
| Muscle, Skeletal | 4 | 2012 | 328 | 0.370 |
Why?
|
| Imidazoles | 4 | 2018 | 59 | 0.360 |
Why?
|
| Luminescent Proteins | 1 | 2010 | 8 | 0.360 |
Why?
|
| Biological Transport | 2 | 2008 | 40 | 0.360 |
Why?
|
| Heart Rate | 3 | 2020 | 107 | 0.350 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 86 | 0.350 |
Why?
|
| Angiotensin II | 3 | 2023 | 7 | 0.340 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2009 | 307 | 0.340 |
Why?
|
| Phosphorylation | 7 | 2017 | 135 | 0.330 |
Why?
|
| Cell Line | 8 | 2007 | 240 | 0.330 |
Why?
|
| Oxidative Stress | 2 | 2007 | 100 | 0.320 |
Why?
|
| Nitric Oxide Synthase Type III | 5 | 2014 | 14 | 0.320 |
Why?
|
| Amitriptyline | 1 | 2008 | 4 | 0.320 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2008 | 17 | 0.320 |
Why?
|
| Permeability | 5 | 2011 | 127 | 0.320 |
Why?
|
| Female | 23 | 2021 | 13844 | 0.310 |
Why?
|
| Osmolar Concentration | 9 | 2006 | 26 | 0.310 |
Why?
|
| Cytoplasm | 5 | 2010 | 35 | 0.310 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 232 | 0.300 |
Why?
|
| Models, Biological | 5 | 2017 | 299 | 0.290 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 2004 | 6 | 0.290 |
Why?
|
| Ornithine | 2 | 2005 | 3 | 0.290 |
Why?
|
| Ion Channels | 5 | 2005 | 187 | 0.290 |
Why?
|
| Muscles | 4 | 1991 | 59 | 0.280 |
Why?
|
| Ventricular Function | 5 | 2007 | 13 | 0.280 |
Why?
|
| Sugar Phosphates | 1 | 2006 | 1 | 0.280 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 4 | 2013 | 6 | 0.270 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 3 | 2017 | 26 | 0.270 |
Why?
|
| Piperazines | 2 | 2018 | 75 | 0.270 |
Why?
|
| Time Factors | 9 | 2020 | 1327 | 0.270 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2018 | 80 | 0.270 |
Why?
|
| Disease Models, Animal | 4 | 2014 | 512 | 0.270 |
Why?
|
| Oxidation-Reduction | 4 | 2021 | 66 | 0.260 |
Why?
|
| Electric Conductivity | 8 | 2004 | 75 | 0.260 |
Why?
|
| Green Fluorescent Proteins | 3 | 2010 | 26 | 0.260 |
Why?
|
| Membrane Potential, Mitochondrial | 4 | 2015 | 8 | 0.260 |
Why?
|
| Pyruvates | 2 | 2003 | 3 | 0.240 |
Why?
|
| Subcellular Fractions | 2 | 2002 | 15 | 0.240 |
Why?
|
| Myocardial Infarction | 1 | 2006 | 139 | 0.240 |
Why?
|
| Cardiac Pacing, Artificial | 3 | 2014 | 25 | 0.240 |
Why?
|
| Polyphosphates | 3 | 2015 | 3 | 0.240 |
Why?
|
| Endothelin-1 | 4 | 2010 | 7 | 0.230 |
Why?
|
| Acrylamides | 1 | 2004 | 4 | 0.230 |
Why?
|
| Antioxidants | 1 | 2024 | 55 | 0.220 |
Why?
|
| Autophagy | 2 | 2021 | 30 | 0.220 |
Why?
|
| Ferrets | 9 | 1999 | 13 | 0.220 |
Why?
|
| Oxygen | 2 | 2021 | 73 | 0.220 |
Why?
|
| Calcium, Dietary | 1 | 2023 | 13 | 0.220 |
Why?
|
| Cardiac Conduction System Disease | 1 | 2022 | 2 | 0.210 |
Why?
|
| Apamin | 1 | 2022 | 4 | 0.210 |
Why?
|
| Models, Animal | 3 | 2012 | 94 | 0.210 |
Why?
|
| Boron Compounds | 3 | 2007 | 5 | 0.210 |
Why?
|
| Potassium Channels | 2 | 2018 | 39 | 0.210 |
Why?
|
| Cell Size | 3 | 1999 | 8 | 0.210 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2021 | 43 | 0.210 |
Why?
|
| Sulfonamides | 5 | 2007 | 39 | 0.200 |
Why?
|
| Electric Stimulation | 9 | 2007 | 59 | 0.200 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 4 | 2005 | 23 | 0.200 |
Why?
|
| Sarcolemma | 3 | 2017 | 9 | 0.200 |
Why?
|
| Acetylcholine | 4 | 2003 | 10 | 0.200 |
Why?
|
| Cyclic GMP | 3 | 2014 | 8 | 0.200 |
Why?
|
| Pyruvic Acid | 4 | 2007 | 5 | 0.190 |
Why?
|
| Fatty Acids | 1 | 2021 | 38 | 0.190 |
Why?
|
| Tamoxifen | 1 | 2021 | 24 | 0.190 |
Why?
|
| Phosphates | 2 | 2015 | 19 | 0.190 |
Why?
|
| Receptors, Estrogen | 1 | 2021 | 57 | 0.190 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 61 | 0.180 |
Why?
|
| Thapsigargin | 4 | 2011 | 7 | 0.180 |
Why?
|
| Apoptosis | 2 | 2018 | 187 | 0.180 |
Why?
|
| Indoles | 3 | 2000 | 36 | 0.170 |
Why?
|
| Isoproterenol | 3 | 2012 | 14 | 0.170 |
Why?
|
| Calcium-Binding Proteins | 2 | 2006 | 22 | 0.170 |
Why?
|
| Protein Isoforms | 2 | 2010 | 42 | 0.170 |
Why?
|
| Nitroprusside | 2 | 2002 | 6 | 0.170 |
Why?
|
| Adenoviridae | 2 | 2010 | 10 | 0.170 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2011 | 137 | 0.160 |
Why?
|
| Oxidative Phosphorylation | 2 | 2013 | 7 | 0.160 |
Why?
|
| Purinergic Agonists | 1 | 1999 | 1 | 0.160 |
Why?
|
| Fibroblasts | 1 | 2019 | 57 | 0.160 |
Why?
|
| Adrenergic beta-Agonists | 3 | 2012 | 17 | 0.160 |
Why?
|
| Mice | 8 | 2021 | 1197 | 0.160 |
Why?
|
| Sp1 Transcription Factor | 1 | 2018 | 6 | 0.160 |
Why?
|
| Membrane Proteins | 1 | 1999 | 150 | 0.160 |
Why?
|
| Muscle Contraction | 2 | 2011 | 67 | 0.160 |
Why?
|
| Xanthenes | 4 | 2006 | 8 | 0.160 |
Why?
|
| Microelectrodes | 7 | 1994 | 31 | 0.160 |
Why?
|
| Phenylephrine | 2 | 2010 | 6 | 0.150 |
Why?
|
| Aniline Compounds | 4 | 2006 | 39 | 0.150 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2006 | 304 | 0.150 |
Why?
|
| Electrophysiology | 6 | 2003 | 102 | 0.150 |
Why?
|
| Hydrogen | 2 | 2003 | 9 | 0.150 |
Why?
|
| Calcium Channel Blockers | 2 | 2008 | 35 | 0.150 |
Why?
|
| Fura-2 | 3 | 1995 | 3 | 0.150 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 341 | 0.150 |
Why?
|
| Superoxides | 3 | 2015 | 26 | 0.150 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2007 | 40 | 0.140 |
Why?
|
| Synaptic Transmission | 2 | 1994 | 27 | 0.140 |
Why?
|
| Intracellular Space | 1 | 2017 | 6 | 0.140 |
Why?
|
| Hypertension | 1 | 2019 | 234 | 0.140 |
Why?
|
| Cytoskeleton | 1 | 1997 | 36 | 0.140 |
Why?
|
| Neurons | 3 | 1994 | 287 | 0.140 |
Why?
|
| Synapses | 2 | 1994 | 33 | 0.140 |
Why?
|
| Rana temporaria | 3 | 1991 | 10 | 0.140 |
Why?
|
| Myometrium | 1 | 1996 | 2 | 0.140 |
Why?
|
| Oxytocin | 1 | 1996 | 7 | 0.140 |
Why?
|
| Muscle, Smooth | 1 | 1996 | 13 | 0.140 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 175 | 0.140 |
Why?
|
| Benzylamines | 2 | 2007 | 11 | 0.140 |
Why?
|
| Light | 2 | 2011 | 74 | 0.130 |
Why?
|
| Cell Lineage | 1 | 2015 | 24 | 0.130 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2015 | 4 | 0.130 |
Why?
|
| Government Programs | 1 | 2015 | 2 | 0.130 |
Why?
|
| Neoplasms | 1 | 2018 | 213 | 0.130 |
Why?
|
| Homeostasis | 2 | 2007 | 51 | 0.130 |
Why?
|
| Bradykinin | 1 | 1995 | 3 | 0.130 |
Why?
|
| 3-Hydroxybutyric Acid | 2 | 2007 | 2 | 0.120 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2015 | 8 | 0.120 |
Why?
|
| Ischemia | 1 | 2015 | 23 | 0.120 |
Why?
|
| Heart Diseases | 1 | 2015 | 59 | 0.120 |
Why?
|
| Calcium Channel Agonists | 2 | 2009 | 4 | 0.120 |
Why?
|
| Buffers | 3 | 2003 | 13 | 0.120 |
Why?
|
| Dendrites | 1 | 1994 | 10 | 0.120 |
Why?
|
| Embryonic Stem Cells | 1 | 2014 | 11 | 0.110 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2014 | 8 | 0.110 |
Why?
|
| Cell Line, Tumor | 3 | 2021 | 232 | 0.110 |
Why?
|
| Acetyl-CoA C-Acyltransferase | 1 | 2013 | 1 | 0.110 |
Why?
|
| Oligomycins | 1 | 2013 | 1 | 0.110 |
Why?
|
| Electron Transport | 1 | 2013 | 5 | 0.110 |
Why?
|
| Proton Ionophores | 1 | 2013 | 2 | 0.110 |
Why?
|
| Blood Pressure | 1 | 2014 | 200 | 0.110 |
Why?
|
| Proton-Translocating ATPases | 1 | 2013 | 5 | 0.110 |
Why?
|
| Carrier Proteins | 2 | 1991 | 83 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2012 | 186 | 0.110 |
Why?
|
| Glutathione | 2 | 2006 | 23 | 0.100 |
Why?
|
| Diffusion | 2 | 2008 | 27 | 0.100 |
Why?
|
| Cell Membrane Permeability | 3 | 2011 | 57 | 0.100 |
Why?
|
| Models, Cardiovascular | 3 | 2020 | 18 | 0.100 |
Why?
|
| Photobleaching | 1 | 2011 | 3 | 0.100 |
Why?
|
| Muscle Relaxants, Central | 1 | 2011 | 3 | 0.100 |
Why?
|
| Aequorin | 1 | 1991 | 1 | 0.100 |
Why?
|
| Phosphodiesterase Inhibitors | 2 | 2003 | 17 | 0.100 |
Why?
|
| Iodoacetates | 2 | 2002 | 2 | 0.100 |
Why?
|
| Calsequestrin | 2 | 2009 | 37 | 0.100 |
Why?
|
| Oxygen Consumption | 1 | 2011 | 35 | 0.100 |
Why?
|
| Microscopy, Electron | 3 | 2015 | 63 | 0.100 |
Why?
|
| Guinea Pigs | 4 | 1998 | 29 | 0.090 |
Why?
|
| Feedback, Physiological | 2 | 2008 | 12 | 0.090 |
Why?
|
| Cardiomegaly | 1 | 2010 | 11 | 0.090 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 24 | 0.090 |
Why?
|
| Protein Transport | 1 | 2010 | 31 | 0.090 |
Why?
|
| HEK293 Cells | 1 | 2010 | 52 | 0.090 |
Why?
|
| Mice, Knockout | 4 | 2010 | 233 | 0.090 |
Why?
|
| Intracellular Fluid | 2 | 2001 | 6 | 0.090 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2000 | 12 | 0.090 |
Why?
|
| Cell Separation | 2 | 2007 | 25 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2007 | 128 | 0.080 |
Why?
|
| Trifluoperazine | 1 | 2009 | 3 | 0.080 |
Why?
|
| MCF-7 Cells | 2 | 2021 | 15 | 0.080 |
Why?
|
| Ventricular Function, Left | 1 | 2009 | 41 | 0.080 |
Why?
|
| Fluorescence Resonance Energy Transfer | 2 | 2005 | 3 | 0.080 |
Why?
|
| Cerebral Cortex | 4 | 1994 | 161 | 0.080 |
Why?
|
| Microsomes | 1 | 2008 | 16 | 0.080 |
Why?
|
| Biological Transport, Active | 2 | 2005 | 14 | 0.080 |
Why?
|
| Ginsenosides | 1 | 2008 | 1 | 0.080 |
Why?
|
| Computer Simulation | 3 | 2020 | 191 | 0.080 |
Why?
|
| Cardiotonic Agents | 2 | 2007 | 10 | 0.080 |
Why?
|
| Carnivora | 1 | 1988 | 1 | 0.080 |
Why?
|
| Manganese | 2 | 2000 | 3 | 0.080 |
Why?
|
| RNA | 1 | 2007 | 32 | 0.070 |
Why?
|
| tert-Butylhydroperoxide | 1 | 2007 | 1 | 0.070 |
Why?
|
| Nuclear Envelope | 1 | 2007 | 3 | 0.070 |
Why?
|
| Lipid Bilayers | 1 | 2007 | 52 | 0.070 |
Why?
|
| Membrane Transport Modulators | 1 | 2007 | 3 | 0.070 |
Why?
|
| Adenosine | 1 | 2007 | 8 | 0.070 |
Why?
|
| Heparin | 1 | 2007 | 21 | 0.070 |
Why?
|
| Animals, Newborn | 3 | 2006 | 42 | 0.070 |
Why?
|
| Deoxyglucose | 1 | 2007 | 3 | 0.070 |
Why?
|
| Iodoacetic Acid | 1 | 2007 | 2 | 0.070 |
Why?
|
| Extracellular Fluid | 1 | 2007 | 2 | 0.070 |
Why?
|
| Antimetabolites | 1 | 2007 | 14 | 0.070 |
Why?
|
| Algorithms | 3 | 2013 | 351 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2018 | 31 | 0.070 |
Why?
|
| Anesthetics, Local | 1 | 2007 | 76 | 0.070 |
Why?
|
| Software | 1 | 2007 | 65 | 0.070 |
Why?
|
| Pulse | 1 | 2006 | 5 | 0.070 |
Why?
|
| Ethylenediamines | 1 | 2006 | 4 | 0.070 |
Why?
|
| Muscle Cells | 1 | 2006 | 11 | 0.070 |
Why?
|
| Cell Communication | 2 | 2019 | 23 | 0.070 |
Why?
|
| Ruthenium Red | 1 | 2006 | 8 | 0.070 |
Why?
|
| Feedback | 1 | 2006 | 29 | 0.070 |
Why?
|
| Cyclic AMP | 2 | 2017 | 21 | 0.060 |
Why?
|
| Biosensing Techniques | 1 | 2005 | 12 | 0.060 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2005 | 1 | 0.060 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2005 | 10 | 0.060 |
Why?
|
| Nitrogen Oxides | 1 | 2005 | 1 | 0.060 |
Why?
|
| Tetrodotoxin | 5 | 2003 | 7 | 0.060 |
Why?
|
| Insurance, Health | 1 | 1985 | 18 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2005 | 97 | 0.060 |
Why?
|
| Cell Compartmentation | 2 | 1998 | 10 | 0.060 |
Why?
|
| Diastole | 2 | 2020 | 33 | 0.060 |
Why?
|
| Peptides | 1 | 2005 | 93 | 0.060 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2004 | 2 | 0.060 |
Why?
|
| Cnidarian Venoms | 1 | 2004 | 1 | 0.060 |
Why?
|
| Ouabain | 1 | 2004 | 1 | 0.060 |
Why?
|
| Central Nervous System Stimulants | 2 | 2009 | 37 | 0.060 |
Why?
|
| Rheumatic Diseases | 1 | 1985 | 54 | 0.060 |
Why?
|
| Cell Survival | 2 | 2015 | 102 | 0.060 |
Why?
|
| Rana pipiens | 2 | 2012 | 53 | 0.060 |
Why?
|
| Arginine Vasopressin | 2 | 1995 | 4 | 0.060 |
Why?
|
| beta-Cyclodextrins | 1 | 2003 | 4 | 0.060 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2003 | 20 | 0.060 |
Why?
|
| Metalloporphyrins | 1 | 2003 | 3 | 0.060 |
Why?
|
| Multienzyme Complexes | 1 | 2003 | 26 | 0.060 |
Why?
|
| Free Radical Scavengers | 1 | 2003 | 11 | 0.060 |
Why?
|
| Vasodilator Agents | 1 | 2003 | 24 | 0.060 |
Why?
|
| Caveolae | 1 | 2003 | 18 | 0.060 |
Why?
|
| Capillary Permeability | 1 | 2003 | 26 | 0.060 |
Why?
|
| Flavoproteins | 1 | 2003 | 1 | 0.060 |
Why?
|
| Adenosine Diphosphate | 1 | 2003 | 5 | 0.060 |
Why?
|
| Lactic Acid | 1 | 2003 | 10 | 0.060 |
Why?
|
| Oscillometry | 2 | 2000 | 7 | 0.060 |
Why?
|
| Triiodothyronine | 1 | 2003 | 6 | 0.050 |
Why?
|
| Sodium Channels | 1 | 2003 | 15 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2002 | 33 | 0.050 |
Why?
|
| Inositol | 1 | 2021 | 7 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2007 | 642 | 0.050 |
Why?
|
| Nickel | 2 | 2000 | 30 | 0.050 |
Why?
|
| Ryanodine | 2 | 2003 | 19 | 0.050 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2021 | 15 | 0.050 |
Why?
|
| Calcium Channels, T-Type | 1 | 2001 | 1 | 0.050 |
Why?
|
| Biophysical Phenomena | 2 | 1998 | 29 | 0.050 |
Why?
|
| Biophysics | 2 | 1998 | 35 | 0.050 |
Why?
|
| Tachycardia | 1 | 2001 | 9 | 0.050 |
Why?
|
| Digitonin | 1 | 2000 | 1 | 0.050 |
Why?
|
| Indicators and Reagents | 1 | 2000 | 9 | 0.050 |
Why?
|
| Clonazepam | 1 | 2000 | 26 | 0.050 |
Why?
|
| Protein Kinase C | 1 | 2001 | 45 | 0.050 |
Why?
|
| Biological Clocks | 1 | 2000 | 16 | 0.040 |
Why?
|
| Dogs | 1 | 2020 | 176 | 0.040 |
Why?
|
| Dithiothreitol | 1 | 1999 | 3 | 0.040 |
Why?
|
| Rhodamines | 1 | 1999 | 5 | 0.040 |
Why?
|
| Fluorescence | 1 | 1999 | 10 | 0.040 |
Why?
|
| Solutions | 2 | 2011 | 17 | 0.040 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 1994 | 26 | 0.040 |
Why?
|
| Mathematics | 2 | 1990 | 31 | 0.040 |
Why?
|
| Carbocyanines | 1 | 1999 | 2 | 0.040 |
Why?
|
| Microspheres | 1 | 1999 | 23 | 0.040 |
Why?
|
| Particle Size | 1 | 1999 | 53 | 0.040 |
Why?
|
| Echocardiography | 1 | 2019 | 103 | 0.040 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2018 | 3 | 0.040 |
Why?
|
| Egtazic Acid | 1 | 1998 | 12 | 0.040 |
Why?
|
| Organic Chemicals | 1 | 1998 | 7 | 0.040 |
Why?
|
| Extracellular Space | 1 | 1998 | 11 | 0.040 |
Why?
|
| Chelating Agents | 1 | 1998 | 11 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 1998 | 32 | 0.040 |
Why?
|
| Cations, Divalent | 1 | 1998 | 11 | 0.040 |
Why?
|
| Membrane Lipids | 1 | 1998 | 16 | 0.040 |
Why?
|
| Cyclosporine | 1 | 1998 | 12 | 0.040 |
Why?
|
| Potassium | 2 | 2008 | 64 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2014 | 16 | 0.040 |
Why?
|
| 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 1997 | 2 | 0.040 |
Why?
|
| Tacrolimus | 1 | 1996 | 16 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2010 | 358 | 0.030 |
Why?
|
| Nifedipine | 1 | 1996 | 7 | 0.030 |
Why?
|
| Macrolides | 1 | 2015 | 4 | 0.030 |
Why?
|
| Caspase 8 | 1 | 2015 | 9 | 0.030 |
Why?
|
| Age Factors | 2 | 2010 | 720 | 0.030 |
Why?
|
| Chloroquine | 1 | 2015 | 7 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2015 | 26 | 0.030 |
Why?
|
| Cellular Senescence | 1 | 2015 | 14 | 0.030 |
Why?
|
| Medical Informatics Computing | 1 | 2015 | 1 | 0.030 |
Why?
|
| Inventions | 1 | 2015 | 1 | 0.030 |
Why?
|
| Chromones | 2 | 2007 | 8 | 0.030 |
Why?
|
| Morpholines | 2 | 2007 | 13 | 0.030 |
Why?
|
| Therapies, Investigational | 1 | 2015 | 5 | 0.030 |
Why?
|
| Systems Biology | 1 | 2015 | 7 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 63 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 23 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2015 | 99 | 0.030 |
Why?
|
| Universities | 1 | 2015 | 35 | 0.030 |
Why?
|
| Forecasting | 1 | 2015 | 85 | 0.030 |
Why?
|
| Cell Death | 1 | 2015 | 40 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1995 | 26 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2015 | 41 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 69 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2015 | 117 | 0.030 |
Why?
|
| Serine | 1 | 2014 | 9 | 0.030 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2014 | 6 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2014 | 21 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1994 | 16 | 0.030 |
Why?
|
| Phorbol Esters | 1 | 1994 | 1 | 0.030 |
Why?
|
| Glutamates | 1 | 1994 | 10 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 1994 | 25 | 0.030 |
Why?
|
| Epidermal Growth Factor | 1 | 2014 | 27 | 0.030 |
Why?
|
| Neuronal Plasticity | 1 | 1994 | 34 | 0.030 |
Why?
|
| Hemoglobins | 1 | 1994 | 75 | 0.030 |
Why?
|
| Gene Expression | 1 | 2014 | 176 | 0.030 |
Why?
|
| Cell Respiration | 1 | 2012 | 1 | 0.030 |
Why?
|
| Reperfusion Injury | 1 | 2012 | 7 | 0.030 |
Why?
|
| Luminescent Measurements | 1 | 1991 | 18 | 0.020 |
Why?
|
| Astrocytes | 1 | 1993 | 113 | 0.020 |
Why?
|
| Isoquinolines | 2 | 2007 | 12 | 0.020 |
Why?
|
| Calibration | 2 | 1990 | 18 | 0.020 |
Why?
|
| Diacetyl | 1 | 1991 | 2 | 0.020 |
Why?
|
| Cell Physiological Phenomena | 1 | 1991 | 6 | 0.020 |
Why?
|
| Ammonium Chloride | 1 | 1991 | 1 | 0.020 |
Why?
|
| Amiloride | 1 | 1991 | 5 | 0.020 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 1991 | 7 | 0.020 |
Why?
|
| Isotonic Solutions | 1 | 1991 | 10 | 0.020 |
Why?
|
| Periodicity | 1 | 1991 | 12 | 0.020 |
Why?
|
| Aorta | 1 | 1991 | 14 | 0.020 |
Why?
|
| Perfusion | 1 | 1991 | 17 | 0.020 |
Why?
|
| Rest | 1 | 1991 | 30 | 0.020 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2010 | 3 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2012 | 202 | 0.020 |
Why?
|
| Physical Exertion | 1 | 2010 | 4 | 0.020 |
Why?
|
| Calcineurin | 1 | 2010 | 9 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2011 | 76 | 0.020 |
Why?
|
| Malonates | 1 | 1990 | 1 | 0.020 |
Why?
|
| Ligands | 1 | 1990 | 37 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 1990 | 84 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 183 | 0.020 |
Why?
|
| Calpain | 1 | 2009 | 2 | 0.020 |
Why?
|
| Ions | 1 | 1990 | 54 | 0.020 |
Why?
|
| United States | 1 | 2015 | 1899 | 0.020 |
Why?
|
| Phenotype | 1 | 2010 | 283 | 0.020 |
Why?
|
| Quality Control | 1 | 1988 | 26 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2007 | 5 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2007 | 9 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2007 | 6 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2006 | 36 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2006 | 26 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 300 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2005 | 20 | 0.020 |
Why?
|
| COS Cells | 1 | 2005 | 35 | 0.020 |
Why?
|
| Plasmids | 1 | 2005 | 35 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 438 | 0.020 |
Why?
|
| Switzerland | 1 | 1985 | 8 | 0.020 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2004 | 2 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 1985 | 276 | 0.010 |
Why?
|
| Antimycin A | 1 | 2003 | 1 | 0.010 |
Why?
|
| Onium Compounds | 1 | 2003 | 1 | 0.010 |
Why?
|
| Pyridazines | 1 | 2003 | 3 | 0.010 |
Why?
|
| Electron Transport Complex I | 1 | 2003 | 2 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2003 | 20 | 0.010 |
Why?
|
| Molecular Weight | 1 | 2003 | 29 | 0.010 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2003 | 1 | 0.010 |
Why?
|
| Rotenone | 1 | 2003 | 11 | 0.010 |
Why?
|
| Pertussis Toxin | 1 | 2003 | 2 | 0.010 |
Why?
|
| Atropine | 1 | 2003 | 4 | 0.010 |
Why?
|
| Receptors, Muscarinic | 1 | 2003 | 5 | 0.010 |
Why?
|
| Cyclodextrins | 1 | 2003 | 9 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 29 | 0.010 |
Why?
|
| Dizocilpine Maleate | 2 | 1994 | 4 | 0.010 |
Why?
|
| Myocardial Stunning | 1 | 2001 | 2 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2001 | 45 | 0.010 |
Why?
|
| Citric Acid Cycle | 1 | 2000 | 1 | 0.010 |
Why?
|
| Adolescent | 1 | 1985 | 1998 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 1996 | 31 | 0.010 |
Why?
|
| Species Specificity | 1 | 1996 | 40 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1994 | 136 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1994 | 173 | 0.010 |
Why?
|
| Intercellular Junctions | 1 | 1993 | 9 | 0.010 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 1993 | 28 | 0.010 |
Why?
|
| Adult | 1 | 1985 | 7087 | 0.010 |
Why?
|
| Kainic Acid | 1 | 1992 | 1 | 0.010 |
Why?
|
| 2-Amino-5-phosphonovalerate | 1 | 1992 | 1 | 0.010 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 1992 | 1 | 0.010 |
Why?
|
| Picrotoxin | 1 | 1992 | 2 | 0.010 |
Why?
|
| Quinoxalines | 1 | 1992 | 7 | 0.010 |
Why?
|
| Fetus | 1 | 1992 | 32 | 0.010 |
Why?
|
| Middle Aged | 1 | 1985 | 8135 | 0.010 |
Why?
|
| Aged | 1 | 1985 | 8397 | 0.010 |
Why?
|
| Normal Distribution | 1 | 1990 | 6 | 0.010 |
Why?
|